Page last updated: 2024-08-23

paclitaxel and Wet Macular Degeneration

paclitaxel has been researched along with Wet Macular Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agostini, HT; Evers, C; Gross, N; Hansen, LL; Hua, J; Martin, G; Michaelis, U; Ranjbar, M; Schulze, B1

Other Studies

1 other study(ies) available for paclitaxel and Wet Macular Degeneration

ArticleYear
Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
    Molecular vision, 2013, Volume: 19

    Topics: Angiogenesis Inhibitors; Animals; Choroidal Neovascularization; Disease Models, Animal; Drug Delivery Systems; Humans; Liposomes; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Paclitaxel; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prodrugs; Vascular Endothelial Growth Factor A; Verteporfin; Wet Macular Degeneration

2013